The median OS of patients bearing mutant vs. wild-type APC/CTNNB1 melanomas was 25.85 vs. 42.5 months (log-rank hazard ratio [HR] 1.42, 95% confidence intervals [95CI] 0.22–12.57, p = 0.69). The gene discussed is APC; the disease is melanoma.